--- title: "Pre-market hot trades in US stocks: Rubico pre-market down 7.67%, reverse split raises market concerns about whether shareholder trading efficiency can be improved?" type: "News" locale: "en" url: "https://longbridge.com/en/news/282329456.md" description: "Rubico pre-market down 7.67%; iSpecimen pre-market up 70.95%; Wellgistics Health pre-market up 45.19%; XPeng pre-market up 38.20%" datetime: "2026-04-10T10:32:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282329456.md) - [en](https://longbridge.com/en/news/282329456.md) - [zh-HK](https://longbridge.com/zh-HK/news/282329456.md) --- # Pre-market hot trades in US stocks: Rubico pre-market down 7.67%, reverse split raises market concerns about whether shareholder trading efficiency can be improved? **Pre-market Hot Trades in US Stocks** Rubico is down 7.67% in pre-market trading. Based on recent key news: 1. On April 7, Rubico announced a 1-for-10 reverse stock split, leading to a drop in stock price. The company's move aims to increase the stock price to maintain compliance with Nasdaq listing requirements, with the outstanding shares expected to decrease from 7,573,572 shares to approximately 757,356 shares. 2. On April 8, Rubico confirmed that the reverse stock split would take effect on April 9, and the stock would trade at the adjusted price on Nasdaq. After the split, fractional shares will be settled at the closing price on April 8. 3. On April 7, Rubico's board approved the reverse stock split, aiming to simplify the company's stock structure and improve shareholder trading efficiency. With increased market volatility, investors should exercise caution. **Top Gainers in Pre-market US Stocks** iSpecimen is up 70.95% in pre-market trading. Based on recent key news: 1. On April 9, iSpecimen issued a new forward-looking statement indicating that the company's business, financial condition, and operational results may undergo significant changes due to future events and circumstances. Investors are reminded not to overly rely on these forward-looking statements, and the company does not undertake any obligation to update or revise these statements. This announcement may have sparked optimistic expectations in the market regarding the company's future development, driving a significant increase in stock price. 2. On April 9, the company's press release further emphasized the content of the aforementioned forward-looking statements, reiterating the changes and uncertainties the company may face in the future. This information may have bolstered investor confidence in the company's future growth potential, leading to a notable rise in stock price. 3. No other significant news recently. Market optimism regarding the company's future development has driven the stock price up. Wellgistics Health is up 45.19% in pre-market trading. Based on recent key news: 1. On April 9, Wellgistics Health announced the termination of its settlement agreement with Silverback Capital, opting to pursue other strategic and financing plans. This move is seen as a strategic adjustment for the company, potentially enhancing market confidence and driving the stock price up. Source: Reuters 2. On April 7, the company released relevant information through the EDGAR system, emphasizing its sole responsibility for the information. This increase in transparency may further enhance investor confidence. Source: Public Technologies 3. On April 9, Wellgistics Health director Eric Michael Sherb submitted an initial Form 3 statement, demonstrating transparency and compliance in the company's internal governance, which may have a positive impact on the stock price. Source: Public Technologies The market reacted positively to the company's strategic adjustments, with significant capital inflow Xiao i Robot pre-market rose 38.20%. Based on recent key news: 4. On April 7, the Supreme People's Court rejected Apple's request, and Xiao i Robot achieved a legal victory. This victory solidifies its position in the competitive AI market, enhancing market credibility and future growth prospects. According to Benzinga Pro data, Xiao i Robot's stock price rose 32.50% in pre-market trading on Tuesday. 5. On April 9, market risk appetite decreased, leading to increased volatility in stocks related to emerging technologies. Xiao i Robot's stock price fell 20.98% in pre-market trading on Thursday. 6. On April 8, Apple faced threats of antitrust lawsuits and lacked new growth points, leading to a decline in its stock price. Although this is not directly related to Xiao i Robot, the market's attention to the AI sector has increased. The competition in the AI industry is fierce, and market volatility is significant ### Related Stocks - [RUBI.US](https://longbridge.com/en/quote/RUBI.US.md) ## Related News & Research - [Why Is Penny Stock Rubico (RUBI) Up Today?](https://longbridge.com/en/news/286917844.md) - [Rubico Inc. Announces Acquisition of Newbuilding Mega Yacht | RUBI Stock News](https://longbridge.com/en/news/271247684.md) - [Rubico Raises $4 Million in Dilutive Unit Offering to Bolster Fleet-Focused Growth](https://longbridge.com/en/news/272465707.md) - [Stock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026— Baidu, Rubico, Intelligent Bio Solutions In Focus](https://longbridge.com/en/news/271325840.md)